Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NAD-dependent protein deacetylase sirtuin-3 (SIRT3) is a member of the mammalian sirtuin family of proteins, homologs to yeast Sir2, and functions as a major mitochondrial protein deacetylase[1]. SIRT3 catalyzes NAD+-dependent removal of acetyl groups from lysine residues on mitochondrial proteins, playing critical roles in regulating mitochondrial metabolism, energy production, cell survival, adaptation to stress, aging, and epigenetic control. SIRT3 deacetylates various substrates, including mitochondrial ribosomal protein MRPL10 and ceramide synthases, thus influencing mitochondrial protein synthesis and ceramide metabolism[4][6]. SIRT3 exists in two isoforms, with the shorter form active in mitochondria and the long isoform found in other cellular compartments[5]. Altered SIRT3 activity is implicated in diverse diseases, including aging-linked disorders, cardiovascular disease, neurodegeneration, metabolic syndromes, and cancer, and it is being evaluated as a therapeutic target and biomarker for mitochondrial function[5][4].
NAD+-dependent deacetylation of lysine residues on target proteins (removal of acetyl groups using NAD+ as cofactor), regulation of substrate activity (such as ceramide synthases, mitochondrial ribosomal proteins, or histone proteins), possibly mono-ADP-ribosylation[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NAD-dependent protein deacetylase sirtuin-3 (SIRT3).